Attached files
| file | filename |
|---|---|
| EX-99.1 - EXHIBIT 99.1 - UTAH MEDICAL PRODUCTS INC | exhibit_99-1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (date of earliest event reported): October 22, 2015
Commission File No. 001-12575
UTAH MEDICAL PRODUCTS, INC.
(Exact name of Registrant as specified in its charter)
| UTAH | 87-0342734 |
| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |
7043 South 300 West
Midvale, Utah 84047
Address of principal executive offices
Registrant's telephone number: (801) 566-1200
ITEM 2.02. RESULTS OF OPERATIONS AND FINANCIAL CONDITION
Attached hereto as Exhibit 99.1 and incorporated by reference herein is financial information for Utah Medical Products, Inc. for the three and nine months ended September 30, 2015 and forward-looking statements relating to 2015 and beyond as presented in a press release dated October 22, 2015. The information in this report shall be deemed incorporated by reference into any registration statement heretofore or hereafter filed under the Securities Act of 1933, as amended, except to the extent that such information is superseded by information as of a subsequent date that is included in or incorporated by reference into such registration statement. The information in this report shall not be treated as filed for purposes of the Securities Exchange Act of 1934, as amended.
ITEM 9.01 EXHIBITS
Index
Number Description
|
|
99.1
|
Financial information for Utah Medical Products, Inc. for the three and nine months ended September 30, 2015 and forward-looking statements relating to 2015 and beyond as presented in a press release dated October 22, 2015.
|
Pursuant to the requirements of the Securities Exchanges Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| UTAH MEDICAL PRODUCTS, INC. | |
| REGISTRANT | |
| Date: 10/22/2015 | By: /s/ Kevin L. Cornwell |
| Kevin L. Cornwell | |
| CEO |